The Effects of Potassium Citrate on Bone Metabolism

Completed · Phase 4 · Has a placebo group

Conditions studied: Bone Diseases, Metabolic, Osteoporosis, Postmenopausal

In brief

Skeletal buffering of chronic acid loads may contribute to a significant amount of bone loss over time. Evidence from a few small short-term studies suggests that basic compounds, namely potassium citrate and potassium bicarbonate may reduce bone loss and improve bone density. The purpose of this study is to evaluate the effects of potassium citrate on bone metabolism. We hypothesize that administration of potassium citrate to postmenopausal women with osteopenia will reduce bone resorption and improve bone mineral density. Postmenopausal women with osteopenia (T score between -1.0 and -2.5) and no history of fracture will be randomized to either daily potassium citrate or placebo for one year. Primary outcomes will be markers of bone turnover, which will be measured over 12 months. Secondary outcomes will be bone mineral density, compliance, and adverse events.

Key facts

Study ID
NCT00357331
Run by
Weill Medical College of Cornell University
People needed
83
Starts
2006-08-01
Expected to finish
2011-04-01
Last updated by the study team
2017-06-12

Who can join

Age: 45 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.